XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   124,865,485      
Beginning balance at Dec. 31, 2022 $ 314,924 $ 12 $ 455,330 $ (1,854) $ (138,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   907      
Issuance of common stock upon exercise of vested stock options 1   1    
Stock-based compensation expense 2,860   2,860    
Other comprehensive income (loss) 895     895  
Net loss (14,965)       (14,965)
Ending balance (in shares) at Mar. 31, 2023   124,866,392      
Ending balance at Mar. 31, 2023 303,715 $ 12 458,191 (959) (153,529)
Beginning balance (in shares) at Dec. 31, 2023   125,068,601      
Beginning balance at Dec. 31, 2023 $ 265,353 $ 13 467,834 (255) (202,239)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares) 196,414 196,414      
Issuance of common stock upon exercise of vested stock options $ 245   245    
Stock-based compensation expense 3,114   3,114    
Other comprehensive income (loss) (490)     (490)  
Net loss (18,730)       (18,730)
Ending balance (in shares) at Mar. 31, 2024   125,265,015      
Ending balance at Mar. 31, 2024 $ 249,492 $ 13 $ 471,193 $ (745) $ (220,969)